Barbora Weinbergerova

Masaryk University

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Francesca Farina

IRCCS San Raffaele Scientific Institute

ITALY

View details

Julian Ronnacker

University of Münster

GERMANY

View details

José-Ángel Hernández-Rivas

SPAIN

View details

Caroline Besson

FRANCE

View details

Rémy Duléry

INSERM

FRANCE

View details

Andreas Glenthøj

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Barbora Weinbergerova

Research Interests

Contact this professor

Articles (10)

Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis

Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups

Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry

MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience

Collaborators (6)

Francesca Farina

Julian Ronnacker

José-Ángel Hernández-Rivas

Caroline Besson

Rémy Duléry

Andreas Glenthøj

Make your next move.